Galecto Inc expected to post a loss of 71  cents a share - Earnings Preview

Damora Therapeutics

01/08/2022 15:01

* Galecto Inc  GLTO.OQ   GLTO.O  is expected to show no
change in
quarterly revenue when it reports  results 
    * ​Refinitiv's mean analyst estimate for Galecto Inc is for
a loss
of 71 cents per share. For the same quarter last year, the
company reported a loss of 50 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Galecto Inc
is
$10​, above​ its last closing price of $1.61. ​​​

This summary was machine generated August 1 at 14:01 GMT.  All
figures in US dollars  unless otherwise stated